ICAAC 2005

HIV: Extra Drug Fails to Improve on Triple Therapy

Roy Gulick, Weill Cornell Medical College, New York
Although the logic in antiretroviral HIV therapy has, for some years, been that two drugs are better than one; and three are better than two, this has not continued. A late breaking study involving 700 patients presented on this at ICAAC found that four drugs are not better than three, but that a worrying relationship exists between race and time to virologic failure.

Click here for all the interviews from ICAAC 2005

Similar Interviews

  • Audio Journal of Cardiovascular Medicine 11.1, January 2005
  • Reporting from: American Heart Association Scientific Sessions, New Orleans, November 7-10, 2004 Scientific Editors: Michael Petch, Papworth Hospital, Cambridge Man Fai Shiu, Walsgrave Hospital,

  • Audio Journal of Cardiovascular Medicine 11.1, January 2005
  • Reporting from: American Heart Association Scientific Sessions, New Orleans, November 7-10, 2004 In this edition: In severe heart failure, Teresa De Marco told

  • Audio Journal of Cardiovascular Medicine: “RADIANCE-1″ Study: Cholesteryl Ester Transfer Protein Inhibitor Fails to Benefit Patients with Familial Hypercholesterolemia">Audio Journal of Cardiovascular Medicine: “RADIANCE-1″ Study: Cholesteryl Ester Transfer Protein Inhibitor Fails to Benefit Patients with Familial Hypercholesterolemia
  • JOHN KASTELEIN, Academic Medical Center, Amsterdam REFERENCE: Abstract 407-7, American College of Cardiolgy New Orleans A drug which raises HDL and reduces

    Post a comment

    Subscribe to Audio Medica Podcast